APA (7th ed.) Citation

Okada, M., Hanayama, M., Yamamoto, Y., Miyake, T., Yoshida, O., Takeshita, E., . . . Hiasa, Y. (2025). Effect of pemafibrate in reducing intestinal long-chain fatty acid absorption and hepatic fibrosis in metabolic dysfunction-associated steatohepatitis rats. BMC Gastroenterology, 25(1), 1. https://doi.org/10.1186/s12876-025-03967-z

Chicago Style (17th ed.) Citation

Okada, Masaya, Masakazu Hanayama, Yasunori Yamamoto, Teruki Miyake, Osamu Yoshida, Eiji Takeshita, Yoshio Ikeda, and Yoichi Hiasa. "Effect of Pemafibrate in Reducing Intestinal Long-chain Fatty Acid Absorption and Hepatic Fibrosis in Metabolic Dysfunction-associated Steatohepatitis Rats." BMC Gastroenterology 25, no. 1 (2025): 1. https://doi.org/10.1186/s12876-025-03967-z.

MLA (9th ed.) Citation

Okada, Masaya, et al. "Effect of Pemafibrate in Reducing Intestinal Long-chain Fatty Acid Absorption and Hepatic Fibrosis in Metabolic Dysfunction-associated Steatohepatitis Rats." BMC Gastroenterology, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12876-025-03967-z.